Movement disorder society unified parkinson disease rating scale experiences in daily living: Longitudinal changes and correlation with other assessments

Movement Disorders

Volumn 28, Issue 14, 2013, Pages 1980-1986

  Lang, Anthony E ^a   Eberly, Shirley ^b   Goetz, Christopher G ^c   Stebbins, Glenn ^c   Oakes, David ^b   Marek, Ken ^d   Ravina, Bernard ^e   Tanner, Caroline M ^f,g   Shoulson, Ira ^h  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF ROCHESTER   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

^d INSTITUTE FOR NEURODEGENERATIVE DISORDERS   (United States)

^e BIOGEN   (United States)

^f PARKINSON S INSTITUTE   (United States)

^g STANFORD UNIVERSITY   (United States)

^h GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Disability; MDS UPDRS; Parkinson's disease; Rating scales

Indexed keywords

AMANTADINE; DOPAMINE RECEPTOR STIMULATING AGENT; DOPAMINE TRANSPORTER; LEVODOPA; MONOAMINE OXIDASE B INHIBITOR;

ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DISEASE DURATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; GERIATRIC DEPRESSION SCALE; HOPKINS VERBAL LEARNING TEST; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MINI MENTAL STATE EXAMINATION; MOVEMENT DISORDER SOCIETY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NEUROPSYCHIATRIC INVENTORY SEVERITY AND DISTRESS SCORE; PARKINSON DISEASE; PERSONAL EXPERIENCE; PRIORITY JOURNAL; QUALITY OF LIFE; QUALITY OF LIFE QUESTIONNAIRE; RATING SCALE; SCORING SYSTEM; UNIFIED PARKINSON DISEASE RATING SCALE; VERBAL FLUENCY LETTER NUMBER SEQUENCING;

DISABILITY; MDS-UPDRS; PARKINSON'S DISEASE; RATING SCALES;

ACTIVITIES OF DAILY LIVING; AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MENTAL STATUS SCHEDULE; MIDDLE AGED; PARKINSON DISEASE; SEVERITY OF ILLNESS INDEX; SOCIETIES, MEDICAL; STATISTICS AS TOPIC; TIME FACTORS;

EID: 84889682335     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.25671     Document Type: Article

References (21)

1. Goetz CG, Tilley BC, Shaftman SR, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 2008;23:2129-2170.
2. Gallagher DA, Goetz CG, Stebbins G, Lees AJ, Schrag A. Validation of the MDS-UPDRS Part I for nonmotor symptoms in Parkinson's disease. Mov Disord 2012;27:79-83.
3. Fahn S, Oakes D, Shoulson I, et al. Levodopa and the progression of Parkinson's disease. N Engl J Med 2004;351:2498-2508.
4. 123I) β-CIT and single-photon emission computed tomographic imaging vs clinical evaluation in Parkinsonian syndrome: unmasking an early diagnosis. Arch Neurol 2004;61:1224-1229.
5. Shoulson I, Schwid S, Hyson C, et al. Mixed lineage kinase inhibitor CEP-1347 fails to delay disability in early Parkinson disease. Neurology 2007;69:1480-1490.
6. Ravina B, Tanner C, DiEuliis D, et al. A longitudinal program for biomarker development in Parkinson's disease: a feasibility study. Mov Disord 2009;24:2081-2090.
7. Fahn S, Elton RL, Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Goldstein M, Calne DB, eds. Recent Development in Parkinson's Disease. Vol.2 Florham Park, New Jersey, USA: Macmillan; 1987:153-163.
8. Fitzpatrick R, Peto V, Jenkinson C, Greenhall R, Hyman N. Health-related quality of life in Parkinson's disease: a study of outpatient clinic attenders. Mov Disord 1997;12:916-922.
9. Folstein M, Folstein S, McHugh P. "Mini Mental State". A practical method for grading the cognitive state of patients for clinicians. J Psychiatr Res 1975;12:189-198.
10. Nasreddine ZS, Phillips NA, Bedirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005;53:695-699.
11. Hoehn MM, Yahr DM. Parkinsonism: Onset, progression and mortality. Neurology 1967;17:427-442.
12. McRae C, Diem G, Vo A, O'Brien C, Seeberger L. Schwab & England: standardization of administration. Mov Disord 2000;15:335-336.
13. Weintraub D, Oehlberg KA, Katz IR, Stern MB. Test characteristics of the 15-item geriatric depression scale and Hamilton depression rating scale in Parkinson disease. Am J Geriatr Psychiatry 2006;14:169-175.
14. Hogervorst E, Combrinck M, Lapuerta P, Rue J, Swales K, Budge M. The Hopkins Verbal Learning Test and screening for dementia. Dement Geriatr Cogn Disord 2002;13:13-20.
15. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994;44:2308-2314.
16. Chaudhuri KR, Healy DG, Schapira AH. Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol 2006;5:235-245.
17. Williams JR, Hirsch ES, Anderson K, et al. A comparison of nine scales to detect depression in Parkinson disease: which scale to use? Neurology 2012;78:998-1006.
18. Larner AJ. Addenbrooke's Cognitive Examination (ACE) for the diagnosis and differential diagnosis of dementia. Clin Neurol Neurosurg 2007;109:491-494.
19. Marinus J, Visser M, Verwey NA, et al. Assessment of cognition in Parkinson's disease. Neurology 2003;61:1222-1228.
20. Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB: a frontal assessment battery at bedside. Neurology 2000;55:1621-1626.
21. Lim SY, Fox SH, Lang AE. Overview of the extranigral aspects of Parkinson disease. Arch Neurol 2009;66:167-172.